GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical™, a company developing a novel bioabsorbable technology for percutaneous vessel closure, today announced the appointment of Robert (Chip) Hance to the company’s Board of Directors.
Hance is a 25-year veteran of the medical device industry. He is the former CEO of Creganna, a private equity-backed Ireland-based supplier to the minimally invasive medical device industry, where he led its successful acquisition by TE Connectivity.
